|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 551216-551225 of 2348971 (234898 Page(s) Totally)
<< < 55117 55118 55119 55120 55121 55122 55123 55124 55125 55126 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2000 |
Lipid Formation and Fine Structure of Marine Microalga Isochrysis sp. CCMP 1324.
|
劉清標; Liu, Ching Piao |
| 國立臺灣大學 |
2010 |
Lipid Formulations of Amphotericin B and Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis Reply
|
孫幸筠; SUN, HSIN-YUN |
| 國立臺灣大學 |
2009 |
Lipid Formulations of Amphotericin B Significantly Improve Outcome in Solid Organ Transplant Recipients with Central Nervous System Cryptococcosis
|
孫幸筠; SUN, HSIN-YUN |
| 臺大學術典藏 |
2018-09-10T07:19:59Z |
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
|
Sun, H.-Y. and Alexander, B.D. and Lortholary, O. and Dromer, F. and Forrest, G.N. and Lyon, G.M. and Somani, J. and Gupta, K.L. and Del Busto, R. and Pruett, T.L. and Sifri, C.D. and Limaye, A.P. and John, G.T. and Klintmalm, G.B. and Pursell, K. and Stosor, V. and Morris, M.I. and Dowdy, L.A. and Munoz, P. and Kalil, A.C. and Garcia-Diaz, J. and Orloff, S. and House, A.A. and Houston, S. and Wray, D. and Huprikar, S. and Johnson, L.B. and Humar, A. and Razonable, R.R. and Husain, S. and Singh, N.; HSIN-YUN SUN |
| 臺大學術典藏 |
2009 |
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
|
Forrest G.N.; Dromer F.; Lortholary O.; Alexander B.D.; HSIN-YUN SUN; Houston S.; House A.A.; Orloff S.; Garcia-Diaz J.; Kalil A.C.; Munoz P.; Lyon G.M.; Somani J.; Gupta K.L.; Del Busto R.; Pruett T.L.; Sifri C.D.; Limaye A.P.; John G.T.; Klintmalm G.B.; Pursell K.; Stosor V.; Morris M.I.; Dowdy L.A.; Wray D.; Huprikar S.; Johnson L.B.; Humar A.; Razonable R.R.; Husain S.; Singh N. |
| 臺大學術典藏 |
2018-09-10T14:51:58Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas, P. and Sension, M. and Arribas, J. and Duiculescu, D. and Florence, E. and Hung, C.-C. and Wilkin, T. and Vanveggel, S. and Stevens, M. and Deckx, H.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:38Z |
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-infected adults treated with rilpivirine or efavirenz for 96 weeks in the ECHO and THRIVE trials
|
Tebas P.; Sension M.; Arribas J.; Duiculescu D.; Florence E.; CHIEN-CHING HUNG; Wilkin T.; Vanveggel S.; Stevens M.; Deckx H. |
| 臺大學術典藏 |
2022-09-09T05:50:01Z |
Lipid lowering in primary prevention: The lower is better, but where to settle?
|
WEI-SHIUNG YANG |
| 國立成功大學 |
2018-09 |
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients
|
Li;Yi-Heng;Chao;Ting-Hsing;Liu;-Yen, Ping;Ueng;Kwo-Chang;Yeh;Hung-I |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
Showing items 551216-551225 of 2348971 (234898 Page(s) Totally)
<< < 55117 55118 55119 55120 55121 55122 55123 55124 55125 55126 > >>
View [10|25|50] records per page
|
